BridgeBio Pharma, Inc.
US ˙ NasdaqGS ˙ US10806X1028

SecurityBBIO / BridgeBio Pharma, Inc.
InstitutionInvesco Ltd.
Latest Disclosed Ownership4,592,814 shares
Latest Disclosed Value $ 341,062,368
Invesco Ltd. reports 4.94% decrease in ownership of BBIO / BridgeBio Pharma, Inc.

On May 12, 2026 - Invesco Ltd. filed a 13F-HR form disclosing ownership of 4,592,814 shares of BridgeBio Pharma, Inc. (US:BBIO) valued at $341,062,368 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 19, 2026 disclosing 4,831,305 shares of BridgeBio Pharma, Inc.. This represents a change in shares of -4.94% during the quarter. The current value of the position is $309,234,167 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F BRIDGEBIO PHARMA COM 10806X102 4,592,814 -238,491 -4.94 341,062 -7.71 0.0065
2026-02-19 2025-12-31 13F BRIDGEBIO PHARMA COM 10806X102 4,831,305 902,648 22.98 369,547 81.10 0.0567
2025-11-13 2025-09-30 13F BRIDGEBIO PHARMA COM 10806X102 3,928,657 1,127,592 40.26 204,054 68.71 0.0321
2025-08-13 2025-06-30 13F BRIDGEBIO PHARMA COM 10806X102 2,801,065 594,902 26.97 120,950 58.59 0.0206
2025-05-12 2025-03-31 13F BRIDGEBIO PHARMA COM 10806X102 2,206,163 1,313,036 147.02 76,267 211.20 0.0144
2025-02-13 2024-12-31 13F BRIDGEBIO PHARMA COM 10806X102 893,127 35,670 4.16 24,507 12.26 0.0045
2024-11-12 2024-09-30 13F BRIDGEBIO PHARMA COM 10806X102 857,457 -231,263 -21.24 21,831 -20.84 0.0042
2024-08-13 2024-06-30 13F BRIDGEBIO PHARMA COM 10806X102 1,088,720 90,095 9.02 27,577 -10.69 0.0058
2024-05-14 2024-03-31 13F BRIDGEBIO PHARMA COM 10806X102 998,625 -273,911 -21.52 30,877 -39.90 0.0066
2024-02-13 2023-12-31 13F BRIDGEBIO PHARMA COM 10806X102 1,272,536 112,383 9.69 51,372 67.92 0.0122
2023-11-13 2023-09-30 13F BRIDGEBIO PHARMA COM 10806X102 1,160,153 475,684 69.50 30,593 159.88 0.0082
2023-08-11 2023-06-30 13F BRIDGEBIO PHARMA COM 10806X102 684,469 631,161 1,183.99 11,773 1,233.18 0.0031
2023-05-12 2023-03-31 13F BRIDGEBIO PHARMA COM 10806X102 53,308 10,681 25.06 884 172.53 0.0002
2023-02-13 2022-12-31 13F BRIDGEBIO PHARMA COM 10806X102 42,627 -276,255 -86.63 325 -89.78 0.0001
2022-11-14 2022-09-30 13F BRIDGEBIO PHARMA COM 10806X102 318,882 275,673 638.00 3,170 708.67 0.0010
2022-08-15 2022-06-30 13F BRIDGEBIO PHARMA COM 10806X102 43,209 -981 -2.22 392 -12.69 0.0001
2022-05-16 2022-03-31 13F BRIDGEBIO PHARMA COM 10806X102 44,190 -3,649 -7.63 449 -43.73 0.0001
2022-02-14 2021-12-31 13F BRIDGEBIO PHARMA COM 10806X102 47,839 -5,027 -9.51 798 -67.80 0.0002
2021-11-15 2021-09-30 13F BRIDGEBIO PHARMA COM 10806X102 52,866 6,207 13.30 2,478 -12.90 0.0006
2021-08-17 2021-06-30 13F BRIDGEBIO PHARMA COM 10806X102 46,659 22,185 90.65 2,845 88.79 0.0007
2021-05-17 2021-03-31 13F BRIDGEBIO PHARMA COM 10806X102 24,474 -12,058 -33.01 1,507 -41.99 0.0004
2021-02-16 2020-12-31 13F BRIDGEBIO PHARMA COM 10806X102 36,532 30,631 519.08 2,598 1,070.27 0.0008
2020-11-16 2020-09-30 13F BRIDGEBIO PHARMA COM 10806X102 5,901 5,901 222 0.0001
2020-08-14 2020-06-30 13F BRIDGEBIO PHARMA COM 10806X102 0 -9,792 -100.00 0 -100.00
2020-05-15 2020-03-31 13F BRIDGEBIO PHARMA COM 10806X102 9,792 2,941 42.93 284 18.33 0.0001
2020-02-14 2019-12-31 13F BRIDGEBIO PHARMA COM 10806X102 6,851 6,851 240 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.